ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 745

Cardiac Involvements Are Related to Poor Prognosis in Patients with Takayasu’s Arteritis in China

Yujiao Wang1, Lili Ma 1, Yan Yan 2, Ying Sun 3, Yongshi Wang 4, Xiaomin Dai 1, Zongfei Ji 5, Lingying Ma 1, Huiyong Chen 3 and Lindi Jiang 1, 1Zhongshan Hospital, Fudan University, Shanghai, China (People's Republic), 2Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, P. R. China, Shanghai, China (People's Republic), 3Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, P. R. China, Shanghai, 4Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai, P. R. China, Shanghai, 5Department of Rheumatology, Zhongshan hospital, Fudan University, Shanghai, China (People's Republic)

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: cardiac structure and follow up, Takayasu.s arteritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I: Takayasu's Arteritis & Polymyalgia Rheumatica

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Heart involvements are closely associated with prognosis in patients with Takayasu’s arteritis (TA). This study was aimed to assess the long-term adverse outcomes of cardiac structure and function and their underlying risk factors in TA.

Methods: One hundred and ninety-eight patients, diagnosed as TA, at the Department of Rheumatology, Zhongshan Hospital from January 2012 to December 2017 were recruited in the present study. Patients were divided into normal, mild and severe groups based on the severity of cardiac structure and function impairment. Data, including demographics, clinical characteristics, treatment at baseline, and cardiac outcomes during long-term follow-up were collected.

Results: 60.1% (119/198) patients exhibited heart involvement on echocardiography. 70.6% (84/119) and 79.8% (95/119) cases showed pathological valvular and atrioventricular abnormalities, respectively. The median follow-up duration of patients with heart involvement was 14.25 (8.47-24.92) months, and more than two echocardiography were performed. 3 cases of death were noted. That onset age (p=0.005) and baseline interleukin-6 level (p= 0.031) were risk factors for the deterioration of cardiac structure. Using normal group as a reference, the risk of worsening cardiac structure (p< 0.001) and function (p< 0.001) was greatest in the severe group, with hazard ratios (HRs) of 13.2 (95% CI, 4.4–39.5) and 52.6 (95% CI, 6.8–403.9)respectively, which mostly occurred within 2 years after onset.

Conclusion: The prognosis of TA patients with severe cardiac structure and function impairment is relatively poor, particularly during the first 2 years after onset.


Table1

Table 1. Echocardiographic values in patients with Takayasu arteritis in different groups.


Table2

Table 2. Comparison of clinical features at baseline among different groups.


figure 4

Figure 4. Survival curve indicating the deterioration rate of cardiac structure in the normal, mild and severe groups.


Disclosure: Y. Wang, None; L. Ma, None; Y. Yan, None; Y. Sun, None; Y. Wang, None; X. Dai, None; Z. Ji, None; L. Ma, None; H. Chen, None; L. Jiang, None.

To cite this abstract in AMA style:

Wang Y, Ma L, Yan Y, Sun Y, Wang Y, Dai X, Ji Z, Ma L, Chen H, Jiang L. Cardiac Involvements Are Related to Poor Prognosis in Patients with Takayasu’s Arteritis in China [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/cardiac-involvements-are-related-to-poor-prognosis-in-patients-with-takayasus-arteritis-in-china/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiac-involvements-are-related-to-poor-prognosis-in-patients-with-takayasus-arteritis-in-china/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology